Why Fifty Changes the Conversation

Between ages 45 and 55, three hormonal axes downshift simultaneously. Growth hormone output drops roughly 14% per decade after thirty. NAD+ levels — the coenzyme that fuels mitochondrial ATP production — fall by as much as 50% between your twenties and your fifties. Telomere attrition, slow but relentless, accelerates once telomerase activity declines. And collagen synthesis — the structural protein behind joint cartilage, skin elasticity and vascular integrity — slows measurably after menopause or andropause.

Each of these declines is well-documented in peer-reviewed endocrinology and gerontology literature. None of them are destiny. Over the past decade, a handful of research peptides have shown the ability to selectively nudge each of these pathways back toward youthful baselines — without the side-effect profile of full hormone replacement.

This article lays out a four-peptide protocol designed specifically for adults over fifty. You will get exact dosing ranges, a clear prioritization ladder (so you can start with one and expand), and a realistic budget breakdown. The full stack costs less than a daily restaurant lunch.

The Four Pillars — and What Each One Does

Pillar 1: NAD+ — Cellular Energy Restoration

Nicotinamide adenine dinucleotide sits at the crossroads of over 500 enzymatic reactions. It is not a vitamin, not a stimulant, and not a hormone — it is the substrate that makes your mitochondria produce ATP. When NAD+ levels drop, cells shift from aerobic respiration toward less efficient pathways. The result: fatigue that sleep cannot fully fix, slower wound healing, impaired DNA repair via sirtuins.

What the research shows: Preclinical and early clinical data suggest that restoring NAD+ levels improves mitochondrial membrane potential, activates SIRT1 and SIRT3, and improves cellular stress resistance. Human trials with NAD+ precursors (NMN, NR) demonstrate measurable improvements in walking endurance and arterial compliance in adults over 55.

Why direct NAD+ matters for 50+: Oral precursors like NMN require multiple enzymatic conversion steps — steps that themselves become less efficient with age. Direct NAD+ supplementation bypasses those bottlenecks entirely, delivering the finished molecule your cells actually need.

Dosing range: 50–250 mg subcutaneous, 1–3 times per week. Start at the low end. Sessions may cause a transient flushing or warmth — this is a normal vasodilatory response and resolves within minutes.

Pillar 2: Epithalon — Telomere Maintenance

Epithalon (epitalon, epithalone) is a synthetic tetrapeptide — Ala-Glu-Asp-Gly — originally developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. Its primary mechanism: activation of telomerase, the enzyme that maintains telomere length on the ends of chromosomes.

Why it matters past fifty: Telomeres shorten with every cell division. Once they reach a critical length, cells enter senescence — they stop dividing but remain metabolically active, secreting inflammatory cytokines (the so-called SASP, or senescence-associated secretory phenotype). This is one of the core engines of age-related chronic inflammation.

Epithalon has been studied across multiple in-vivo models. In Khavinson's longitudinal rodent studies, animals receiving epithalon showed a 13.7% increase in median lifespan compared to controls. Human fibroblast studies demonstrate telomerase reactivation and extended replicative capacity. The peptide also shows pineal gland modulation, supporting endogenous melatonin production — relevant for the sleep architecture disruptions common after fifty.

Dosing range: 5–10 mg subcutaneous daily for 10–20 consecutive days. Standard protocol calls for one cycle every 4–6 months. Some practitioners use a lower maintenance dose of 3–5 mg every other day between cycles.

Pillar 3: Ipamorelin — Growth Hormone Optimization

Ipamorelin is a pentapeptide growth hormone secretagogue that works by selectively stimulating the ghrelin receptor (GHS-R1a) on pituitary somatotroph cells. Unlike older secretagogues (GHRP-6, hexarelin), ipamorelin produces clean GH pulses without significantly raising cortisol, prolactin or aldosterone — a critical distinction for the 50+ population already managing cortisol-driven visceral fat accumulation.

What GH restoration means at fifty: Growth hormone governs lean body mass preservation, bone mineral density maintenance, lipolysis (fat metabolism), deep sleep architecture and immune surveillance. By fifty, your pulsatile GH output is roughly one-third of its peak. Ipamorelin does not inject external GH — it signals your own pituitary to release it in a physiological pulsatile pattern, preserving negative feedback loops.

Practical benefits documented in clinical settings: Improved sleep depth (measured by EEG slow-wave percentage), faster recovery from exercise-induced muscle damage, reduced visceral adiposity on DEXA scans, improved skin turgor and wound healing timelines.

Ipamorelin pairs exceptionally well with NAD+ — GH pulses improve cellular repair capacity, while NAD+ ensures the mitochondria in those cells have the energy substrate to execute repairs.

Dosing range: 200–300 mcg subcutaneous, administered 1–3 times daily (typically before bed and/or upon waking on an empty stomach). GH release is blunted by food-induced insulin spikes, so timing matters: dose at least 30 minutes before eating or 2 hours after a meal.

Pillar 4: GHK-Cu — Tissue Repair and Remodeling

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide-copper chelate found in human plasma, saliva and urine. Plasma levels drop from roughly 200 ng/mL at age 20 to 80 ng/mL by age 60. That 60% decline correlates tightly with the visible and structural changes of aging: thinner skin, slower wound healing, joint cartilage degradation, and reduced hair follicle cycling.

Mechanism breadth: GHK-Cu has been shown to modulate the expression of over 4,000 genes — roughly 6% of the human genome. It upregulates collagen I, collagen III and elastin synthesis. It activates decorin, which in turn regulates TGF-beta signaling to reduce fibrosis and scarring. It chelates copper into enzymatic sites that drive superoxide dismutase (SOD) and other antioxidant enzymes.

For the 50+ user, GHK-Cu addresses the most visible marker of aging (skin laxity, wrinkles, uneven pigmentation) and the most functionally impactful one (joint cartilage and connective tissue integrity). It is the peptide that produces results your mirror and your knees both notice.

Dosing range: Subcutaneous injection: 1–2 mg daily, cycling 4 weeks on / 2 weeks off. Topical: 0.01–0.1% cream applied to target areas (face, neck, hands) once daily. Many practitioners combine both routes — systemic for joint and vascular benefits, topical for focused dermal remodeling.

Prioritization Ladder: Where to Start If You Cannot Do Everything at Once

Budgets, needle comfort, and personal health priorities vary. Here is a clear prioritization framework based on breadth of systemic impact:

Priority 1 — NAD+ (start here). If you do only one thing from this protocol, restore your NAD+ levels. Every other repair pathway in your body — including the ones targeted by the other three peptides — depends on adequate cellular energy. Without sufficient NAD+, your mitochondria are running on a brownout. Ipamorelin-driven GH pulses cannot trigger repair in energy-starved cells. Epithalon-extended telomeres mean little if the cell's power plant is failing. NAD+ is the foundation.

Priority 2 — Ipamorelin. Once cellular energy is restored, optimizing growth hormone output addresses the widest range of age-related decline: body composition, sleep quality, immune function, and tissue repair velocity. Ipamorelin is the broadest-spectrum intervention after NAD+.

Priority 3 — GHK-Cu. With energy restored and GH optimized, adding GHK-Cu accelerates the structural repair cascade — collagen deposition, joint cartilage maintenance, and skin remodeling. Many users report this as the peptide with the most "visible" results within the first cycle.

Priority 4 — Epithalon. Telomere maintenance is a long-game investment. Its benefits compound over years, not weeks. If budget forces a choice, Epithalon cycles can be added once the first three pillars are running. That said, the dosing schedule (10–20 days every 4–6 months) makes it the least expensive intervention per year.

Budget Breakdown: Less Than a Coffee Habit

One of the most persistent myths about peptide protocols is that they require a significant financial commitment. Let us examine the actual numbers for a full four-peptide stack at Peptex pricing:

Peptide	Monthly Usage	Approximate Monthly Cost
NAD+ (250mg vial)	2–4 sessions/week	~€45–65
Epithalon (10mg)	1 cycle every 4–6 months	~€15–20 amortized/month
Ipamorelin (5mg vial)	Daily dosing, 5 days/week	~€50–70
GHK-Cu (50mg vial)	Daily, 4 weeks on/2 off	~€35–50

Total: approximately €145–205/month, or €4.80...